LB 11058
Latest Information Update: 17 Aug 2017
Price :
$50 *
At a glance
- Originator LG Life Sciences
- Class Cephalosporins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gram-positive infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-positive-infections in South Korea (Parenteral)
- 17 May 2004 Data presented at the 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2004) have been added to the Bacterial Infections antimicrobial activity section
- 08 Mar 2004 A preclinical study has been added to the Bacterial Infections antimicrobial activity section